SPECIFIC GLYCAN TARGETING TO ERADICATE CANCER STEM CELLS
$222,319N43FY2014CANIH
Siamab Therapeutics, Inc., Newton MA
Investigators
Abstract
SPECIFIC GLYCAN TARGETING TO ERADICATE CANCER STEM CELLS
View original record on NIH RePORTER →Siamab Therapeutics, Inc., Newton MA
SPECIFIC GLYCAN TARGETING TO ERADICATE CANCER STEM CELLS
View original record on NIH RePORTER →